SEC EDGAR · Company announcement
STE: Financial results · Restructuring
Filed 8-K for an event or period dated 2026-11-04. Financial results; Restructuring.
Follow STE- Became public
- Nov 4, 2026, 4:38 PM EST
- Event / period date
- Nov 4, 2026
- Collected
- Nov 7, 2026, 4:46 PM EST
Why this is connected
This filing identifies STERIS plc as the issuer of the security. The company's SEC identifier connects it to STE.
Press Release issued by STERIS plc on ↗Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, STERIS plc (the “Company” or "STERIS") issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933. Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release issued by STERIS plc on Nov ember 4 , 2026 announcing financial results for its fiscal 2027 second q uarter ending September 30 , 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STERIS plc By /s/ J. Adam Zangerle Name: J. Adam Zangerle Title: Senior Vice President, General Counsel & Company Secretary Dated: November 4, 2026
Congressional trading in STE
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Sep 25, 2026$15K–$50K
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
- Aug 27, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Jul 13, 2026 · disclosed Aug 27, 2026
- Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 31, 2026 · disclosed Aug 3, 2026 · Dependent
Traded 5 days before earnings - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 29, 2026 · disclosed Aug 3, 2026 · Dependent
Traded 7 days before earnings - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 27, 2026 · disclosed Aug 3, 2026 · Dependent
Traded 9 days before earnings
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.